Publications by authors named "Chris Craver"

Claim this Profile
B
Burden of illness associated with overweight and obesity in patients hospitalized with COVID-19 in the United States: analysis of the premier healthcare database from April 1, 2020 to October 31, 2020.
Nina Kim, Abdalla Aly, Chris Craver, W Timothy Garvey

J Med Econ· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palonosetron versus other 5-HT₃ receptor antagonists for prevention of chemotherapy-induced nausea and vomiting in patients with hematologic malignancies treated with emetogenic chemotherapy in a hospital outpatient setting in the United States.
Chris Craver, Julie Gayle, Sanjeev Balu, Deborah Buchner

J Med Econ· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy-induced nausea and vomiting and antiemetic prophylaxis with palonosetron versus other 5-HT3 receptor antagonists in patients with cancer treated with low emetogenic chemotherapy in a hospital outpatient setting in the United States.
Lee Schwartzberg, Gary Morrow, Sanjeev Balu, Chris Craver, Julie Gayle

Curr Med Res Opin· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and economic burden of chemotherapy-induced nausea and vomiting among patients with cancer in a hospital outpatient setting in the United States.
Chris Craver, Julie Gayle, Sanjeev Balu, Deborah Buchner

J Med Econ· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palonosetron versus other 5-HT(3) receptor antagonists for prevention of chemotherapy-induced nausea and vomiting in patients with cancer on chemotherapy in a hospital outpatient setting.
Sanjeev Balu, Deborah Buchner, Chris Craver, Julie Gayle

Clin Ther· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis